Thesis - Life Sciences bibliographies - in Harvard style

In-text: (Aly and Ganesan, 2011)

Your Bibliography: Aly, A. and Ganesan, S., 2011. BRCA1, PARP, and 53BP1: conditional synthetic lethality and synthetic viability. Journal of Molecular Cell Biology, 3(1), pp.66-74.

In-text: (Dasari and Bernard Tchounwou, 2014)

Your Bibliography: Dasari, S. and Bernard Tchounwou, P., 2014. Cisplatin in cancer therapy: Molecular mechanisms of action. European Journal of Pharmacology, 740, pp.364-378.

In-text: (Gilbert, Chalmers and El-Khamisy, 2011)

Your Bibliography: Gilbert, D., Chalmers, A. and El-Khamisy, S., 2011. Topoisomerase I inhibition in colorectal cancer: biomarkers and therapeutic targets. British Journal of Cancer, 106(1), pp.18-24.

In-text: (Kalimutho et al., 2017)

Your Bibliography: Kalimutho, M., Bain, A., Mukherjee, B., Nag, P., Nanayakkara, D., Harten, S., Harris, J., Subramanian, G., Sinha, D., Shirasawa, S., Srihari, S., Burma, S. and Khanna, K., 2017. Enhanced dependency of KRAS-mutant colorectal cancer cells on RAD51-dependent homologous recombination repair identified from genetic interactions in Saccharomyces cerevisiae. Molecular Oncology, 11(5), pp.470-490.

In-text: (Knauf, 2006)

Your Bibliography: Knauf, J., 2006. Oncogenic RAS Induces Accelerated Transition through G2/M and Promotes Defects in the G2 DNA Damage and Mitotic Spindle Checkpoints. Journal of Biological Chemistry, 281(7), pp.3800-3809.

In-text: (Murai et al., 2012)

Your Bibliography: Murai, J., Huang, S., Das, B., Renaud, A., Zhang, Y., Doroshow, J., Ji, J., Takeda, S. and Pommier, Y., 2012. Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors. Cancer Research, 72(21), pp.5588-5599.

In-text: (Panier and Boulton, 2013)

Your Bibliography: Panier, S. and Boulton, S., 2013. Double-strand break repair: 53BP1 comes into focus. Nature Reviews Molecular Cell Biology, 15(1), pp.7-18.

In-text: (Santaguida et al., 2010)

Your Bibliography: Santaguida, S., Tighe, A., D'Alise, A., Taylor, S. and Musacchio, A., 2010. Dissecting the role of MPS1 in chromosome biorientation and the spindle checkpoint through the small molecule inhibitor reversine. The Journal of Cell Biology, 190(1), pp.73-87.

In-text: (Shen, Aoyagi-Scharber and Wang, 2015)

Your Bibliography: Shen, Y., Aoyagi-Scharber, M. and Wang, B., 2015. Trapping Poly(ADP-Ribose) Polymerase. Journal of Pharmacology and Experimental Therapeutics, 353(3), pp.446-457.

In-text: (Suter et al., 2003)

Your Bibliography: Suter, C., Norrie, M., Ku, S., Cheong, K., Tomlinson, I. and Ward, R., 2003. CpG island methylation is a common finding in colorectal cancer cell lines. British Journal of Cancer, 88(3), pp.413-419.

In-text: (Vogel, Kienitz, Müller and Bastians, 2004)

Your Bibliography: Vogel, C., Kienitz, A., Müller, R. and Bastians, H., 2004. The Mitotic Spindle Checkpoint Is a Critical Determinant for Topoisomerase-based Chemotherapy. Journal of Biological Chemistry, 280(6), pp.4025-4028.

In-text: (Weaver and Yang, 2013)

Your Bibliography: Weaver, A. and Yang, E., 2013. Beyond DNA Repair: Additional Functions of PARP-1 in Cancer. Frontiers in Oncology, 3.

In-text: (Zasadil et al., 2014)

Your Bibliography: Zasadil, L., Andersen, K., Yeum, D., Rocque, G., Wilke, L., Tevaarwerk, A., Raines, R., Burkard, M. and Weaver, B., 2014. Cytotoxicity of Paclitaxel in Breast Cancer Is due to Chromosome Missegregation on Multipolar Spindles. Science Translational Medicine, 6(229), pp.229ra43-229ra43.

In-text: (Zhu, Zhou and Shi, 2014)

Your Bibliography: Zhu, Y., Zhou, Y. and Shi, J., 2014. Post-slippage multinucleation renders cytotoxic variation in anti-mitotic drugs that target the microtubules or mitotic spindle. Cell Cycle, 13(11), pp.1756-1764.

In-text: (Zimmermann and de Lange, 2014)

Your Bibliography: Zimmermann, M. and de Lange, T., 2014. 53BP1: pro choice in DNA repair. Trends in Cell Biology, 24(2), pp.108-117.